key: cord-0949864-3m8ekphy
authors: Rhodes, Jonathan M.; Subramanian, Sreedhar; Laird, Eamon; Kenny, Rose Anne
title: Letter: low population mortality from COVID‐19 in countries south of latitude 35° North supports vitamin D as a factor determining severity—authors’ reply
date: 2020-06-02
journal: Aliment Pharmacol Ther
DOI: 10.1111/apt.15823
sha: d817dd99b0ab13eb04a3a571bbcfa4a0eea3e242
doc_id: 949864
cord_uid: 3m8ekphy

We thank Dr Mansur for his interest in our editorial in which we highlighted the association between northern latitude and increased COVID-19 mortality1 and for his helpful comments about the potential importance of vitamin D effects on cathelicidin and on the renin-angiotensin system, which could be important in protecting against severe COVID-19.2 Vitamin D is a secosteroid hormone, derived like cortisol and sex hormones from cholesterol, so not surprisingly it has a broad range of actions reflecting the several hundred or more genes that are vitamin D-responsive.3,4.

We thank Dr Mansur for his interest in our editorial in which we highlighted the association between northern latitude and increased COVID-19 mortality 1 and for his helpful comments about the potential importance of vitamin D effects on cathelicidin and on the reninangiotensin system, which could be important in protecting against severe COVID-19. 2 Vitamin D is a secosteroid hormone, derived like cortisol and sex hormones from cholesterol, so not surprisingly it has a broad range of actions reflecting the several hundred or more genes that are vitamin D responsive. 3, 4 Thrombosis is another aspect of severe COVID-19 illness where vitamin D may be very important, as previously highlighted by Tian and Rong. 5 The lupus anti-coagulant abnormality, characterised by prolonged activated partial thromboplastin time, has recently been reported in COVID-19. 6 This is the coagulopathy associated with anti-phospholipid syndrome in which there is evidence of seasonality 7 and a strong association with vitamin D deficiency. 8 Kawasaki syndrome, currently being reported with increasing incidence while countries are in 'lockdown', also has a winter predominance and here too a causative role for vitamin D deficiency has been suggested. 9 All the associations between vitamin D deficiency and COVID-19 severity are circumstantial but they are stacking up and obtaining more direct evidence will not be easy. If low serum vitamin D levels are found in patients with severe COVID-19 these could reasonably be attributed to the well-recognised negative acute phase reactant response of vitamin D to illness. 10 A controlled trial of vitamin D supplementation would be intellectually neatest but this too will be difficult. Giving vitamin D to patients who are already ill may be too late. A placebo-controlled trial of prophylactic vitamin D in the community might be best but it could be very hard to find people willing to take the chance of being randomised to placebo rather than to a vitamin that is known to be essential-the clue is in the name! If the vitamin D hypothesis is correct, then we would hope to see some reduction of COVID-19 severity in the Northern Hemisphere as we move into summer-provided that people who are not taking supplements get sufficient sunlight. Meanwhile people in the Southern Hemisphere might be well advised to take vitamin D supplements as they move into winter.

The authors' declarations of personal and financial interests are unchanged from those in the original article. 1 

Editorial: low population mortality from COVID-19 in countries south of latitude 35 degrees North supports vitamin D as a factor determining severity

Letter: low population mortality from COVID-19 in countries south of latitude 35 degrees North supports vitamin D as a factor determining severity

New aspects of vitamin D metabolism and action -addressing the skin as source and target

Primary vitamin D target genes of human monocytes

Letter: Covid-19, and vitamin D. Authors' reply

Lupus anticoagulant and abnormal coagulation tests in patients with covid-19

AP&T correspondence columns are restricted to letters discussing papers that have been published in the journal. A letter must have a maximum of 500 words, may contain one table or figure, and should have no more than 10 references. It should be submitted

Seasonal distribution of antiphospholipid antibodies

Vitamin D and antiphospholipid syndrome: a retrospective cohort study and metaanalysis

Severe vitamin D deficiency in patients with Kawasaki disease: a potential role in the risk to develop heart vascular abnormalities?

Does serum 25-hydroxyvitamin D decrease during acute-phase response? A systematic review